Missing novelty in drug development
Year of publication: |
2022
|
---|---|
Authors: | Krieger, Joshua ; Li, Danielle ; Papanikolaou, Dimitris |
Published in: |
The review of financial studies. - Oxford : Oxford University Press, ISSN 1465-7368, ZDB-ID 1467494-4. - Vol. 35.2022, 2, p. 636-679
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Innovation | Risikoaversion | Risk aversion | Pharmakologie | Pharmacology | Investitionsrisiko | Investment risk | Betriebsgröße | Firm size | USA | United States |
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
Evaluating the US pharmaceutical patent policy
Izhak, Olena, (2021)
-
Grewal, Rajdeep, (2008)
- More ...
-
Missing Novelty in Drug Development
Krieger, Joshua, (2018)
-
Krieger, Joshua, (2017)
-
Evaluation and Learning in R&D Investment
Frankel, Alexander P., (2023)
- More ...